M&T Bank’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$132K Buy
23,257
+499
+2% +$2.44K ﹤0.01% 1688
2026
Q1
$97.6K Sell
22,758
-820
-3% -$4.57K ﹤0.01% 1639
2025
Q4
$211K Buy
+23,578
New +$146K ﹤0.01% 1548

Other funds holding NUVB

M&T Bank's NUVB Position: Q2 2026 in Review

M&T Bank increased its Nuvation Bio (NUVB) stake by 2.2% in Q2 2026, buying an estimated $2.44K and bringing the position to 23,257 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

M&T Bank first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $211K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • M&T Bank held 23,257 shares of Nuvation Bio worth $132K as of Q2 2026.
  • M&T Bank bought 499 Nuvation Bio shares in Q2 2026, an estimated $2.44K.
  • Nuvation Bio made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1688 holding.
  • M&T Bank first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • M&T Bank's Nuvation Bio position peaked at $211K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.